Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2002 1
2004 2
2009 1
2010 2
2011 3
2012 8
2013 5
2014 6
2015 2
2016 5
2017 5
2018 6
2019 5
2020 5
2021 6
2022 9
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
First-line imatinib vs second- and third-generation TKIs for chronic-phase CML: a systematic review and meta-analysis.
Vener C, Banzi R, Ambrogi F, Ferrero A, Saglio G, Pravettoni G, Sant M. Vener C, et al. Blood Adv. 2020 Jun 23;4(12):2723-2735. doi: 10.1182/bloodadvances.2019001329. Blood Adv. 2020. PMID: 32559295 Free PMC article.
Imatinib, the first tyrosine kinase inhibitor (TKI) for the treatment of chronic myeloid leukemia (CML), improves overall survival (OS), but the introduction of newer TKIs requires the definition of the optimal first-line TKI for newly diagnosed Philadelphia chromos …
Imatinib, the first tyrosine kinase inhibitor (TKI) for the treatment of chronic myeloid leukemia (CML), improves overall surv …
Chronic Myeloid Leukemia following Exposure to Radioactive Iodine (I131): A Systematic Review.
Ali Hailan YM, Al-Dubai HN, Yassin MA. Ali Hailan YM, et al. Oncology. 2023;101(6):362-368. doi: 10.1159/000530463. Epub 2023 May 9. Oncology. 2023. PMID: 37231874 Free article. Review.
BACKGROUND: Therapy-related leukemia is a term that describes the occurrence of leukemia following exposure to hematotoxins and radiation to emphasize the difference from leukemia that arises de novo. Many agents and host factors contribute to this entity of …
BACKGROUND: Therapy-related leukemia is a term that describes the occurrence of leukemia following exposure to hematotoxins an …
Chronic myelogenous leukemia and benzene exposure: a systematic review and meta-analysis of the case-control literature.
Lamm SH, Engel A, Joshi KP, Byrd DM 3rd, Chen R. Lamm SH, et al. Chem Biol Interact. 2009 Dec 10;182(2-3):93-7. doi: 10.1016/j.cbi.2009.08.010. Epub 2009 Aug 18. Chem Biol Interact. 2009. PMID: 19695237 Review.
Benzene exposure is well demonstrated as a cause of acute myelogenous leukemia, but not of chronic myelogenous leukemia. Previous literature reviews based on case series and cohort studies have not shown an association. We have now conducted a l …
Benzene exposure is well demonstrated as a cause of acute myelogenous leukemia, but not of chronic myelogenous …
Rash with different types of BCR-ABL inhibitors in chronic myelogenous leukemia: a systematic review and meta-analysis.
Li S, Wang T, Zhong Y, Dai S. Li S, et al. Future Oncol. 2023 Jun;19(17):1215-1227. doi: 10.2217/fon-2022-1008. Epub 2023 Jun 27. Future Oncol. 2023. PMID: 37368411 Review.
Objective: A meta-analysis was conducted to systematically review the risks of all-grade as well as high-grade rash in chronic myelogenous leukemia (CML) patients using different types of BCR-ABL inhibitors. ...The results showed that the incide …
Objective: A meta-analysis was conducted to systematically review the risks of all-grade as well as high-grade rash in chronic mye …
SARS-CoV-2 and chronic myeloid leukemia: a systematic review.
Ali EA, Al-Sadi A, Al-Maharmeh Q, Subahi EA, Bellamkonda A, Kalavar M, Panigrahi K, Alshurafa A, Yassin MA. Ali EA, et al. Front Med (Lausanne). 2024 Jan 24;10:1280271. doi: 10.3389/fmed.2023.1280271. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38327268 Free PMC article.
English literature was screened using PubMed, SCOPUS, and Google Scholar. Search terms include chronic myeloid leukemia, chronic myelogenous leukemia, and SARS-CoV-2 and Coronavirus disease 2019 (COVID-19). ...The available data indicates that C …
English literature was screened using PubMed, SCOPUS, and Google Scholar. Search terms include chronic myeloid leukemia, ch …
Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysis.
Gurion R, Gafter-Gvili A, Vidal L, Leader A, Ram R, Shacham-Abulafia A, Paul M, Ben-Bassat I, Shpilberg O, Raanani P. Gurion R, et al. Haematologica. 2013 Jan;98(1):95-102. doi: 10.3324/haematol.2012.063172. Epub 2012 Aug 8. Haematologica. 2013. PMID: 22875617 Free PMC article. Review.
Second generation tyrosine kinase inhibitors have recently been introduced as first-line treatment for chronic phase chronic myelogenous leukemia. We aimed to evaluate the efficacy and safety of 2(nd) generation tyrosine kinase inhibitors versus imatin …
Second generation tyrosine kinase inhibitors have recently been introduced as first-line treatment for chronic phase chronic …
Comparison of cutaneous adverse events between second-generation tyrosine kinase inhibitors and imatinib for chronic myeloid leukemia: a systematic review and meta-analysis.
Cha SH, Kim K, Song YK. Cha SH, et al. Acta Oncol. 2023 Dec;62(12):1767-1774. doi: 10.1080/0284186X.2023.2263152. Epub 2023 Nov 25. Acta Oncol. 2023. PMID: 37787749
BACKGROUND: Patients with chronic myeloid leukemia (CML) treated with tyrosine kinase inhibitors (TKIs) often experience cutaneous adverse events, such as rashes and pruritus. ...MATERIAL AND METHODS: Paired reviewers independently obtained studies from PubMed, Emba …
BACKGROUND: Patients with chronic myeloid leukemia (CML) treated with tyrosine kinase inhibitors (TKIs) often experience cutan …
Avascular necrosis in patients with chronic myeloid leukemia: A systematic review.
Yassin M, Al-Mashdali AF, Al-Dubai HN. Yassin M, et al. Acta Biomed. 2022 Mar 14;93(1):e2022017. doi: 10.23750/abm.v93i1.12270. Acta Biomed. 2022. PMID: 35315390 Free PMC article.
Objective: Avascular necrosis (AVN)has been encountered in hematological malignancies; nonetheless, AVN is extremely uncommon in patients with chronic myeloid leukemia (CML). This review aims to describe the pathophysiology, clinical characteristics, and outcomes of …
Objective: Avascular necrosis (AVN)has been encountered in hematological malignancies; nonetheless, AVN is extremely uncommon in patients wi …
Medication experience and patient's related needs in chronic myeloid leukemia treated with tyrosine kinase inhibitors: Systematic review.
Cachafeiro Pin AI, Villaverde Piñeiro L, Martín Clavo S, Silva Castro MM. Cachafeiro Pin AI, et al. Farm Hosp. 2023 Mar-Apr;47(2):85-92. doi: 10.1016/j.farma.2022.11.002. Epub 2023 Jan 2. Farm Hosp. 2023. PMID: 36599752 Free article. Review. English, Spanish.
OBJECTIVE: Several studies quantitatively described patients with Chronic Myeloid Leukaemia on active treatment with tyrosine kinase inhibitors, however there are few qualitative studies that focus their results on how to accompany patients in the course of the disease ove …
OBJECTIVE: Several studies quantitatively described patients with Chronic Myeloid Leukaemia on active treatment with tyrosine kinase …
Priapism in Patients with Chronic Myeloid Leukemia (CML): A Systematic Review.
Ali E, Soliman A, De Sanctis V, Nussbaumer D, Yassin M. Ali E, et al. Acta Biomed. 2021 Jul 1;92(3):e2021193. doi: 10.23750/abm.v92i3.10796. Acta Biomed. 2021. PMID: 34212918 Free PMC article.
Priapism resulting from hematologic malignancy is most likely caused by venous obstruction from microemboli/thrombi and hyperviscosity caused by the increased number of circulating leukocytes in mature and immature forms. In patients with leukemia, 50% of cases of priapism …
Priapism resulting from hematologic malignancy is most likely caused by venous obstruction from microemboli/thrombi and hyperviscosity cause …
75 results